Mochi Health vs Ro: GLP-1 Weight Loss Programs Compared (2026)
An independent, side-by-side comparison of Mochi Health and Ro for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Mochi Health
Starting at $149/mo vs $149/mo
Most Medications
Mochi Health
2 medications vs 2
Best for Beginners
Ro
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Mochi Health | Ro | Savings |
|---|---|---|---|
| Semaglutide | $149/monthly | $149/monthly | Similar pricing |
| Tirzepatide | Not offered | $299/monthly | Only at Ro |
Pros and Cons
Mochi Health
- Video consultations with board-certified obesity medicine providers
- Registered dietitian access included in membership
- Orforglipron (oral GLP-1) available at $149/mo
- Brand-name injectable GLP-1s available through insurance, plus non-GLP-1 alternatives
- Insurance support with prior authorization handling
- Available in 49 states
- Membership fee is required on top of medication cost
- Lab work not included (recommended but at additional cost)
- Some patients have reported shipping delays
- Early-stage company with limited funding (~$1M raised) compared to established players
- Compounded GLP-1 options permanently unavailable
- Not available in Alabama
Ro
- Competitive compounded semaglutide pricing (from $149/mo)
- Large established platform with millions of patients
- Free ongoing provider messaging
- Body program includes metabolic health coaching
- No video consultations — async only
- No lab testing included
- Only offers GLP-1 weight loss medications
- Compounded medications not FDA-approved as finished products
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 14, 2026
Mochi Health vs Ro: GLP-1 Programs Compared
Mochi Health and Ro represent two distinct strategies for accessing GLP-1 medications. Mochi is built around getting brand-name GLP-1 medications covered by insurance, with board-certified obesity medicine physicians leading care. Ro is built for fast, frictionless cash-pay access to compounded GLP-1 medications. The best choice depends almost entirely on your insurance situation.
Quick Verdict
| Mochi Health | Ro | |
|---|---|---|
| Monthly cost | ~$99/month program fee + insurance copay | $149/month (all-in) |
| Best for | Insurance-covered brand-name GLP-1; specialist care | Fast cash-pay access; tirzepatide |
| Provider type | Board-certified obesity medicine physicians | General medical providers |
| Medication | Brand-name (Wegovy, Zepbound, etc.) via insurance | Compounded semaglutide or tirzepatide |
| Insurance navigation | Core specialization | No |
| Start time | 2–4 weeks (insurance process) | 4–7 days |
| Tirzepatide | Yes (Zepbound via insurance) | Yes (compounded) |
Provider Quality: Mochi's Key Differentiator
Mochi's clinical model stands out in the telehealth GLP-1 space: the platform staffs board-certified obesity medicine specialists rather than general practitioners. This matters because:
- Obesity medicine board certification (from the American Board of Obesity Medicine) requires dedicated training in metabolic disease, GLP-1 pharmacology, and complex weight management cases
- Mochi providers are more likely to understand medication interactions, dose optimization, and the management of non-responders
- Patients with complex comorbidities (diabetes, cardiovascular disease, PCOS, hypothyroidism) receive more specialized care
Ro's provider model: Ro uses licensed medical providers for GLP-1 prescriptions, but this is a generalist model — the focus is on efficient prescription access rather than specialist metabolic care.
Who this matters for: Patients with complex medical histories, multiple comorbidities, or prior GLP-1 treatment failures are better served by Mochi's specialist model. Healthy patients with straightforward obesity seeking basic medication access are well-served by Ro.
Pricing and Cost Structure
| Component | Mochi Health | Ro |
|---|---|---|
| Program fee | ~$99/month | $149/month (includes medication) |
| Medication (with insurance coverage) | Copay (often $0–50/month with savings cards) | N/A |
| Medication (no insurance) | Compounded semaglutide ~$149–199/month | Included |
| Total with good insurance | ~$99–149/month | $149/month |
| Total without insurance | ~$248–298/month (program + compounded) | $149/month |
Insurance math: If Mochi can get you brand-name Wegovy with a $0 copay (via Novo Nordisk savings card for commercially insured patients), your total cost is ~$99/month. If insurance fails and you fall back to compounded, Mochi becomes more expensive than Ro.
Insurance Navigation
Mochi's core value proposition for insurance-eligible patients:
- Prior authorization documentation: Mochi's obesity medicine physicians write detailed medical necessity letters
- Appeals: The team actively works denied claims
- Formulary expertise: Understands which plans have favorable GLP-1 coverage and which are difficult
- Savings card optimization: Ensures eligible patients use manufacturer savings cards
Ro: No insurance navigation. Ro's model is to bypass insurance entirely with cash-pay compounded medication. If insurance navigation is your goal, Ro doesn't serve that need.
Medication Options
| Medication | Mochi Health | Ro |
|---|---|---|
| Brand-name Wegovy (semaglutide) | Yes (via insurance) | No |
| Brand-name Zepbound (tirzepatide) | Yes (via insurance) | No |
| Brand-name Ozempic (semaglutide) | Yes (via insurance) | No |
| Compounded semaglutide | Yes (fallback) | Yes |
| Compounded tirzepatide | Limited | Yes |
| Oral GLP-1 (orforglipron) | Pending | Pending |
Speed to Treatment
| Step | Mochi Health | Ro |
|---|---|---|
| Intake + medical evaluation | 15–20 minutes | 10–15 minutes |
| Provider review | 24–48 hours | Same day–24 hours |
| Insurance prior auth | 1–3 weeks | N/A |
| Shipping | 3–7 days | 3–5 days |
| Total: first dose | 2–4 weeks | ~4–7 days |
Speed is clearly Ro's advantage. The insurance process at Mochi adds 1–3 weeks. For patients who want to start immediately, Ro wins.
Head-to-Head: Who Should Choose Which
Choose Mochi Health if:
- You have insurance that covers or may cover GLP-1 medications
- You want board-certified obesity medicine physician oversight
- You've been denied before and need an active appeals specialist
- You have complex comorbidities warranting specialist management
- You prefer brand-name medication over compounded
Choose Ro if:
- You're paying cash and want the fastest, simplest path
- You want to start within the week
- Tirzepatide via cash-pay is your preference
- You don't need insurance navigation
- You want a flat, predictable $149/month with no variables
Alternatives to Consider
| Provider | Why Consider | Monthly Cost |
|---|---|---|
| Sequence | Insurance-specialist without the specialist physician model | ~$99/month |
| FORM Health | Deepest specialist care; insurance navigation | $149+ |
| Henry Meds | Fastest start, tirzepatide, $129/month after 6 months | $149/month |
| Calibrate | Insurance navigation + year-long program | ~$249 one-time |
Related Resources
- Best GLP-1 with Insurance — insurance navigation platforms ranked
- Best Tirzepatide Providers — tirzepatide access options
- Mochi Health vs Found — another Mochi comparison
- Compounded vs Brand-Name GLP-1 FAQ — safety and quality comparison
- GLP-1 Insurance Coverage Guide — how to get GLP-1 covered
Related Guides
Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know
Complete guide to aleniglipron, Structure Therapeutics' investigational oral GLP-1 showing 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II — the highest weight loss reported for any oral GLP-1 to date. Only 3.7% discontinuation rate. Phase 3 expected H2 2026, with earliest FDA approval in 2028 or later.
Read guide →Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked
Every major GLP-1 weight loss program ranked — real pricing, clinical models, and honest assessments. No provider paid for placement.
Read guide →